Oxford Biomedica【OXB】銘柄情報

Oxford Biomedica (OXB) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

600.00

( - )

買値

598.00

売値

600.00

出来高

0.00

0.00 日の範囲 0.00

305.50 52 週間の範囲 950.00

時価総額

725.523M

前日終値

600.00

始値

時刻

(O)

最終取引時間

財務取引量

VWAP

平均取引量 (3 か月)

287,663p

発行済株式数

120,920,518

配当利回り

PER

-23.4

1 株当たり利益 (EPS)

-0.27

歳入

168.74M

純利益

-30.13M

Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its LentiVector platform technology is a lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with ear... Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its LentiVector platform technology is a lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems; InAAVate, a proprietary ‘plug and play’ dual-plasmid system for transient transfection, as well as a standard triple transfection system for AAV-based gene therapies. The company collaborates with pharmaceutical and biotechnology companies providing viral vector development and manufacturing services in lentivirus, adeno-associated virus, adenoviral vectors, and other viral vector types. The company was formerly known as Pinco 838 Limited and changed its name to Oxford Biomedica plc in October 1996. Oxford Biomedica plc was incorporated in 1996 and is headquartered in Oxford, the United Kingdom. 詳細を表示

セクター

Healthcare

業界

Biotechnology & Life Sciences

ウェブサイト

www.oxb.com

本社

Oxford, United Kingdom

設立

1996

Oxford Biomedica is listed in the Healthcare sector of the ロンドン証券取引所 with ticker OXB. The last closing price for Oxford Biomedica was 600p. Over the last year, Oxford Biomedica shares have traded in a share price range of 305.50p to 950.00p.

Oxford Biomedica currently has 120,920,518 shares in issue. The market capitalisation of Oxford Biomedica is £725.52 million. Oxford Biomedica has a price to earnings ratio (PE ratio) of -23.40.

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-10	-1.6393442623	610	640	591	258988	610.47540423	DE
4	-35	-5.51181102362	635	645	567	337124	606.49413531	DE
12	7	1.18043844857	593	668	530	289114	605.57715256	DE
26	-30	-4.7619047619	630	950	530	340840	681.12998395	DE
52	280	87.5	320	950	305.5	285128	629.91162743	DE
156	133	28.4796573876	467	950	164.4	243609	418.85884744	DE
260	-700	-53.8461538462	1300	1678	164.4	207827	526.61326651	DE